Literatur
- 1
American Thoracic Society .
Standards for the diagnosis and care of patients with chronic obstructive pulmonary
disease.
Am J Respir Crit Care Med.
1995;
152
S77-S120
- 2 Barnes P, Godfrey S. Chronic obstructive pulmonary disease. London: Martin Dunitz
1997
- 3
Petty T L, Weinmann G G.
Building a national strategy for the prevention and management of and research in
chronic obstructive pulmonary disease.
JAMA.
1997;
277
246-253
- 4
British Thoracic Society .
Guidelines for the management of chronic obstructive pulmonary disease.
Thorax.
1997;
52
S1-S28
- 5
Fabbri L M, Caramori G, Beghe B, Papi A, Ciaccia A.
Chronic obstructive pulmonary disease international guidelines.
Curr Opin Pulm Med.
1998;
4
76-84
- 6
Fletcher C, Peto R.
The natural history of chronic airway obstruction.
Br Med J.
1977;
1
1645-1648
- 7
Jeffery P K.
Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1991;
143
1152-1158
- 8
Jeffery P K.
Comparative morphology of the airways in asthma and chronic obstructive pulmonary
disease.
Am J Respir Crit Care Med.
1994;
150
S6-S13
- 9
Oxman A, Muir D CF, Shannon H S, Stock S R, Hnizdo E, Lange H J.
Occupational dust exposure and chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1993;
148
38-48
- 10 Senior R M, Shapiro D. Chronic obstructive pulmonary disease: epidemiology, pathophysiology,
and pathogenesis. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior
RM (Hrsg.). Fishman's pulmonary diseases and disorders New York: McGraw-Hill 1998:
659-681
- 11
Canadian Thoracic Society Workshop Group .
Guidelines for the assessment and management of chronic obstructive pulmonary disease.
Can Med Assoc J.
1992;
147
420-428
- 12 Schäfer H, Ewig S, Gillissen A. Therapie der schweren Exazerbation bei chronisch
obstruktiver Lungenerkrankung (COPD). Intensivmed. 2000b im Druck
- 13
Siafakas N M, Vermeire P, Pride N B, Paoletti P, Gibson J, Howard P, Yernault J C,
Decramer M, Higenbottam T, Postma D S, Rees J.
Optimal assessment and management of chronic obstructive pulmonary disease (COPD).
Eur Respir J.
1995;
8
1398-1420
- 14
Wettengel R, Böhning W, Cegla U, Criée C, Fichter J, Geisler L, Fabel H, Köhler D,
Konietzko N, Lindemann H, Magnussen H, Matthys H, Meister R, Morr H, Nolte D, Petro W,
Schultze-Werninghaus G, Sill V, Sybrecht G W, Wiesner B, Worth H.
Empfehlungen der Deutschen Atemwegsliga zur Behandlung von Patienten mit chronisch
obstruktiver Bronchitis und Lungenemphysem.
Med Klinik.
1995;
90
3-7
- 15
Jackevicius C, Joyce D P, Kesten S, Chapman K R.
Prehospitalization inhaled corticosteroid use in patients with COPD or asthma.
Chest.
1997;
111
296-302
- 16 Kardos P. Differentialdiagnose Asthma - COPD. Münch Med Wschr 2000 im Druck
- 17
Lepage T, Bourcereau J, Terrioux P, Velicitat P, Roche N.
Influence des résultats du test de réversibilité de l'obstruction bronchique sur la
prise en charge de bronchopneumopathies chroniques obstructives (BPCO) en pratique
pneumologique.
Rev Mal Respir.
2000;
17
S25
- 18
Barnes J P.
Inhaled Corticosteroids are not beneficial in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
2000;
161
342-344
- 19
Calverley P MA.
Inhaled Corticosteroids are beneficial in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
2000;
161
341-344
- 20
Gillissen A.
Kortisontherapie bei chronisch-obstruktiver Bronchitis - Contra-Position.
Dtsch Med Wschr.
2000;
125
222-223
- 21 Schäfer H, Ewig S, Gillissen A. Therapeutische Optionen im Management der stabilen
chronisch obstruktiven Lungenerkrankung (COPD). Dtsch Med Wschr 2000a im Druck
- 22
Vogelmeier C.
Kortisontherapie bei chronisch-obstruktiver Bronchitis - Pro-Position.
Dtsch Med Wschr.
2000;
125
220-221
- 23
Vestbo J, Sørensen T, Langer P, Brix A, Torre A, Viskum K.
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary
disease: a randomised controlled trial.
Lancet.
1999;
355
1819-1823
- 24
Pauwels R A, Lofdahl C G, Laitinen L A, Schouten J P, Postma D S, Pride N B, Ohlsson S V.
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive
pulmonary disease who continue smoking.
N Engl J Med.
1999;
340
1948-1953
- 25
Paggiaro P L, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J.
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate
in patients with chronic obstructive pulmonary disease.
Lancet.
1998;
351
773-780
- 26
Burge P S, Calverley P M, Jones P W, Spencer S, Anderson J A, Maslen T K.
Randomised, double blind, placebo-controlled study of fluticasone propionate in patients
with moderate to severe chronic obstructive pulmonary disease; The ISOLDE trial.
BMJ.
2000;
320
1297-1303
- 27
Anthonisen N R, Connett J E, Kiley J P, Altose M D, Bailey W C, Buist A S, Conway
Jr W A, Enright P L, Kanner R E, O'Hara P.
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator
on the rate of decline of FEV1. The Lung Health Study.
JAMA.
1994;
272
1539-1541
- 28
Barnes P J.
New therapies for chronic obstructive pulmonary disease.
Thorax.
1998;
53
137-147
- 29
McEvoy C E, Niewoehner D E.
Adverse effects of corticosteroid therapy for COPD. A critical review.
Chest.
1997;
111
732-743
- 30
Renkema T EJ, Schouten J P, Koeter G H, Postma D S.
Effects of long-term treatment with corticosteroids in COPD.
Chest.
1996;
109
1156-1162
- 31
Bourbeau J, Rouleau M Y, Boucher S.
Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease.
Thorax.
1998;
53
477-482
- 32
Cox G, Whitehead L, Dolovich M, Jordana M, Gauldie J, Newhouse M T.
A randomized controlled trial on the effect of inhaled corticosteroids on airways
inflammation in adult cigarette smokers.
Chest.
1999;
115
1271-1277
- 33
Fujimoto K, Kubo K, Yamamoto H, Yamaguchi S, Matsuzawa Y.
Eosinophilic inflammation in the airway is related to glucocorticoid reversibility
in patients with pulmonary emphysema.
Chest.
1999;
115
697-702
- 34
Confalonieri M, Mainardi E, Della Porta R, Bernorio S, Gandola L, Beghé B, Spanevello A.
Inhaled corticosteroide reduce neutrophilic bronchial inflammation in patients with
chronic obstructive pulmonary disease.
Thorax.
1998;
53
583-585
- 35
Keatings V M, Jatakanon A, Worsdell Y M, Barnes P J.
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and
COPD.
Am J Respir Crit Care Med.
1997;
155
542-548
- 36
Llewellyn-Jones C G, Harris T A, Stockley R A.
Effect of fluticasone propionate on sputum of patients with chronic bronchitis and
emphysema.
Am J Respir Crit Care Med.
1996;
153
616-621
- 37
Efthimiou J, Barnes P J.
Effect of inhaled corticosteroids on bones and growth.
Eur Respir J.
1998;
11
707-709
- 38
Goldstein M F, Fallon Jr J J, Harning R.
Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung
disease.
Chest.
1999;
116
1733-1749
- 39
Calverley P MA.
Re-assessing the evidence about inhaled corticosteroids in chronic obstructive pulmonary
disease.
Thorax.
1999;
54
3-4
- 40
Pizzichini E, Pizzichini M MM, Gibson P, Parameswaran K, Gleich G J, Berman P, Dolovich J,
Hargreave F E.
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive
bronchitis.
Am J Respir Crit Care Med.
1998;
158
1511-1517
- 41
Dompeling E, van Schayck C P, van Grunsven P M, van Herwaarden C LA, Akkermans R P,
Molema J, Folgering H, van Weel C.
Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed
during bronchodilator therapy by adding inhaled corticosteroids.
Ann Intern Med.
1993;
118
770-778
- 42
Prescott E, Langer P, Vestbo J.
Socioeconomic status, lung function and admission to hospital for COPD: results from
the Copenhagen City Heart Study.
Eur Respir J.
1999;
13
1109-1114
- 43
Niewoehner D E, Erbland M L, Deupree R H, Collins D, Gross N J, Light R W, Anderson P,
Morgan N A.
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary
disease.
N Engl J Med.
1999;
340
1941-1947
Prof. Dr A Gillissen
Med. Universitätsklinik und Poliklinik II
Sigmund-Freud-Str. 25 53105 Bonn
Email: E-mail: adrian.gillissen@mailer.meb.uni-bonn.de
